Lysine methylation in EHMT1/GLP acts as a molecular switch to reprogram transcription networks to drive prostate cancer progression.
作者全名："Besschetnova, Anna; Han, Wanting; Liu, Mingyu; Gao, Yanfei; Li, Muqing; Wang, Zifeng; Labaf, Maryam; Patalano, Susan; Venkataramani, Kavita; Muriph, Rachel; Macoska, Jill; Siegfried-Harris, Kellee; Evans, Jason; Balk, Steven; Gao, Shuai; Han, Dong; Cai, Changmeng"
作者地址："[Besschetnova, Anna; Liu, Mingyu; Li, Muqing; Wang, Zifeng; Labaf, Maryam; Patalano, Susan; Venkataramani, Kavita; Muriph, Rachel; Macoska, Jill; Siegfried-Harris, Kellee; Evans, Jason; Gao, Shuai; Han, Dong; Cai, Changmeng] Univ Massachusetts Boston, Boston, MA USA; [Han, Wanting] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Gao, Yanfei] Chongqing Med Univ, Chongqing, Peoples R China; [Balk, Steven] Beth Israel Deaconess Med Ctr, Boston, MA USA"
通信作者：
来源：CANCER RESEARCH
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:000924848300032
JCR分区：Q1
影响因子：11.2
年份：2022
卷号：82
期号：23
开始页：
结束页：
文献类型：Meeting Abstract
关键词：
摘要：
基金机构：
基金资助正文：
